Bioline Rx reported $19.53M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Arca Biopharma USD 486.72M 17.72M Mar/2026
Bio Path USD -8.49M 482K Mar/2026
Bioline Rx USD 19.53M 537K Sep/2025
Capricor Therapeutics USD 278.7M 27.09M Mar/2026